Search results
Found 153 matches for
Researchers at the MRC Weatherall Institute of Molecular Medicine have recently discovered why a class of cancer drugs is beneficial only in a subset of patients. The results could pave the way for the future development of these drugs, known as PNP-inhibitors, as personalised medicines.
Colleen McGregor
Researchers
BSc (Hons) MBBS AICSM MRCP(UK) Colleen McGregor - DPhil Clinical Medicine